NSE filing, NSE: INNOMET. Summary written from the filing by ALFA Finder's alert engine.
Innomet Advanced Materials Ltd: key numbers
- Share price
- ₹372.55
- Market cap
- ₹517.5 Cr
- Revenue (annual)
- ₹53.86 Cr
- Net profit (annual)
- ₹1.57 Cr
- P/E (TTM)
- 329.0×Sector 17.1×
- Promoter holding
- 55.02%
- FII holding
- 1.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Innomet Advanced Materials Ltd
All →Innomet Advanced Materials Earnings Call Transcript: Key Takeaways
H1 FY27 revenue more than doubled to ₹55.7 Cr; PAT ₹4.75 Cr. EBITDA 14.8% remains below 18% a year ago. Growth is price-led; the ₹100 Cr FY27 target leans on orders and the ₹1,000 Cr vision needs new capital.
Innomet Advanced Materials Investor Presentation: Key Takeaways
H1 FY27 consolidated revenue ₹55.7 Cr (+137%), EBITDA ₹8.2 Cr at 14.8% margin, PAT ₹4.75 Cr (+136%). Growth driven by powders, THA and exports; margins diluted by tungsten costs.
Innomet Advanced Materials Other Announcement
Innomet Advanced Materials filed its half-year Reg 32 statement on preferential issue proceeds, with no deviation. Rs.753.25 lakh raised in August 2026 was fully used for working capital.
Innomet Advanced Materials H1 FY27 Results: Net Profit ₹4.8 Cr, Up 140.0% YoY
Innomet Advanced Materials Ltd reported revenue from operations of ₹55.7 Cr (+137.0% YoY) and net profit of ₹4.8 Cr (+140.0% YoY) for H1 FY27.
- Key figure
- Net profit ₹4.8 Cr · +140.0% YoY
Innomet Advanced Materials Convertible Warrants
INNOMET allotted 11,92,200 equity share warrants at ₹210 each to Mr. Mukul Mahavir Agrawal, aggregating ₹25.04 Crore. 25% upfront was received; balance payable on exercise.
- Value
- ₹25.04 Cr
Innomet Advanced Materials Bags ₹0.28 Cr Order from New Metals and Chemicals Corporation, Ltd
Innomet Advanced Materials received a purchase order from Japan's New Metals and Chemicals Corporation. The total order value is approximately ₹0.28 Crore.
- Value
- ₹0.28 Cr
- From
- New Metals and Chemicals Corporation, Ltd
Other board meeting outcome announcements
All →Ennature Bio Pharma Board Meeting Outcome
Ennature Bio Pharma's board approved adoption of new Articles of Association to align with SCRA Rules 1957 and group governance. The change is subject to shareholder approval.
Shri Keshav Cements & Infra Board Meeting Outcome
Shri Keshav Cements' board approved un-audited financial and segment-wise revenue results for the quarter and half-year ended 30 September 2026. No other material decisions were transacted.
Balmer Lawrie Investments Board Meeting Outcome
Balmer Lawrie Investments appointed M/s. K. K. Chanani & Associates as Statutory Auditor for FY 2026-27 under Section 139(5), per a C&AG letter. The appointment is effective from 10 November 2026.
- Execution
- FY 2026-27
Jiwanram Sheoduttrai Industries Board Meeting Outcome
Jiwanram Sheoduttrai's board approved convening its 29th AGM on 30 November 2026 and re-appointing a retiring non-executive director. The board also approved the FY2025-26 Board's Report.
Finolex Cables Board Meeting Outcome
Finolex Cables' board approved amending its insider trading code of conduct on 7 November 2026. Amended code was filed under PIT Regulation 8(2).
Chatterbox Technologies Board Meeting Outcome
Chatterbox's board approved a Rs. 7 crore related-party ceiling with its UAE subsidiary and a vendor change for IPO funds. Monitoring agency and deviation reports were also noted.